The Washington State Capitol Building photographed at night in Olympia, Washington.

Washington State Budget Includes $100K for Hemp Program

a word from our sponsors:

advertisement

advertise here

Washington state’s budget includes $100,000 to license hemp farmers and market hemp products, according to a Capital Press report. The funding – $187,000 less than requested by the Department of Agriculture – allows the program to continue for another year; however, the agency has not yet resumed licensing producers.

The program has been on hold since late last year and officials have not set a timetable for when they will begin licensing farmers for the next season, an Agriculture Department spokesperson told Capital Press. Licensing fees – set at $750paired with grower registration fees of $1,300 were expected to sustain the program but those fell short of the department’s expectations.

Cory Sharp, owner of HempLogic which grew half of the state’s 180 industrial hemp acres planted last year, said he still had unused hemp crops from last season and warned farmers not to plant too many acres. HempLogic will not participate in this year’s program because the company is developing a mobile hemp processor with a Colorado-based equipment maker.

“The processing has just not caught up with the growing. If you do 5 acres and you lose the whole thing, you’re still a hemp farmer, but you didn’t lose the whole farm. … “Maybe in a weird way, Washington, by throwing cold water on it, saved people from making big mistakes.” – Sharp to the Capital Press

Last season the agency issued seven one-year licenses throughout the state and collected $8,139 from licensees; the agency spent $146,000 overseeing the program.

End


The North Dakota Capitol building.

North Dakota MMJ Rules Take Effect Apr. 1

a word from our sponsors:

advertisement

advertise here

The laws governing North Dakota’s medical cannabis program will take effect April 1 after getting the green light from the Legislature’s Administrative Rules Committee, the Bismarck Tribune reports. The voter-approved law was re-written by lawmakers last year, who said that the ballot version was flawed.

Jason Wahl, director of the Health Department’s medical marijuana division, said the agency anticipates opening up applications for manufacturing facilities by the end of this week and, depending on a “number of factors,” medical cannabis could be available to patients before the end of this year.

“Without the rules, this program really cannot move forward. The department is committed to implementing this program as quickly as it can, but needs to ensure that this program is implemented in well-regulated manner.” –  Wahl to the Tribune

There are some concerns that medical cannabis producers could be considered “corporate farms” which would run afoul of a state law preventing corporate farms in the state. Rep Robin Weisz, who as a member of the House Human Services Committee worked on the legislation last session, said that the body added language to “make it clear” medical cannabis companies “were not considered agricultural operations.”

Last August, Health Department regulators announced they were seeking non-binding letters of intent from laboratories interested in testing medical cannabis products.

End


The leafy ceiling of a large, commercial cannabis grow in Washington state.

Arkansas Judge Halts MMJ Cultivator Licensing Following Lawsuit

a word from our sponsors:

advertisement

advertise here

An Arkansas judge has put the state’s licensing of medical cannabis cultivators on hold as one of the unsuccessful applicants vying for a cultivation license is suing the Arkansas Medical Marijuana Commission over the application evaluation process, ArkansasOnline reports. Pulaski County Circuit Judge Wendell Griffen said that the lawsuit by Naturalis Health “asserts facts showing a substantial likelihood of success on the merits regarding violations of the Administrative Procedure Act, due process and equal protection.”

The order ties the hands of the state Department of Finance and Administration, Alcoholic Beverage Control Division, and Medical Marijuana Commission from moving forward with the program pending a preliminary injunction hearing, which is set for tomorrow.

Naturalis was one of two companies that sued the agency yesterday; Attorney General Leslie Rutledge’s office indicated that the state would respond “in due course.” The medical cannabis board had anticipated issuing the five medical cannabis cultivation licenses yesterday, after announcing preliminary approval for the companies March 1.

State regulators have already approved 4,410 medical cannabis patient applications and are expected to approve 32 dispensaries later this year. The Medical Marijuana Commission had received about 95 cultivation applications and 227 dispensary applications.

End


Tim Fair: Launching Vermont’s First Cannabis Law Firm

a word from our sponsors:

advertisement

advertise here

Tim Fair is a Vermont-based cannabis consultant and the owner/founder of Vermont Cannabis Solutions, the state’s first cannabis law practice.

In this episode of the Ganjapreneur.com podcast, Tim joins our podcast host TG Branfalt in his Vermont studio for a conversation about the landmark cannabis reform law passed earlier this year by Vermont’s legislature, the differences between legalization and decriminalization, the state’s vibrant hemp and CBD industry, and what the industry might look like when a tax-and-regulate system is eventually put in place.

Listen to the interview through the player below, or scroll further down to read a full transcript of this week’s Ganjapreneur.com podcast episode!


Listen to the interview:


Read the transcript:

TG Branfalt: Hey there. I’m your host, TG Branfalt, and you’re listening to The Ganjapreneur.com Podcast where we try to bring you actionable information, and normalize cannabis through the stories of ganjapreneurs, activists, and industry stakeholders. Today I’m actually joined in studio by Tim Fair. He’s the owner of Vermont’s first cannabis law practice, Vermont Cannabis Solutions.

Just before we get started, we’ve got to know that nothing that Mr. Fair says should be considered legal advice. Don’t say “Well, Tim Fair said on The Ganjapreneur Podcast that this was totally cool,” because that’s not going to hold up in court. How are you doing this afternoon, man?

Tim Fair: Thank you, TG.

TG Branfalt: Tell me about yourself, man. How’d you end up in the cannabis space?

Tim Fair: At a very early age, I realized that I liked cannabis. As a teenager growing up, seeing all the messages, all of the propaganda, the DARE, all of the anti-drug propaganda we were fed, I started seeing a disconnect. What I was experiencing and what I was hearing were two different stories.

As I got older, I started realizing that everything that we were taught wasn’t necessarily true, and in that line of reasoning, I went ahead and tried to start a chapter of NORML in my very first community college, Long Island Nassau Community College, when I was 17.

Didn’t work out so well, but ever since that point, I’ve always been focused on drug policy reform. Specifically cannabis reform.

TG Branfalt: How long have you been working with cannabis cases from a criminal level?

Tim Fair: I graduated law school in 2012. Lucky enough to pass my bar on the first attempt. Got my first legal job as an attorney in 2013, but didn’t really start learning cannabis law until the last two years. I would say around 2016 I started pretty indepthly studying the subject, and I’ve taken my first cannabis clients about six months ago.

TG Branfalt: So what’s been your experience as an attorney defending cannabis cases in Vermont? I guess what I want to ask you is, did you know racial disparities in these arrests, and how did prosecutors approach such cases?

Tim Fair: A little bit of background before I can fully answer that. We have a unique system here in Vermont. We have 14 counties and each county has its own elected state’s attorney. So, when we’re talking about racial disparities, you have to talk about it in terms of county, as opposed to state, because some counties much better with the issue. Other counties, horrible with it.

Another exacerbating factor has been the surge in opiates, cocaine, crack cocaine, that come in from out of state. That has created a sense of, I don’t want to say racism amongst law enforcement, but definitely focuses their attention on brown and black people.

TG Branfalt: How do prosecutors approach these cases? There’s decriminalization, we just passed legalization, which hasn’t taken effect yet, but are prosecutors still aggressive, even with decriminalization?

Tim Fair: You have to talk about individual prosecutors, individual state’s attorneys. For example, in Chittenden County, where Burlington is located, the state’s attorney’s office does not pursue cannabis cases. They’ve got bigger, better things to do. There is an understanding that in the spectrum of illegal activities, cannabis use is pretty low as you get.

However, I’ve had a client in Essex County, Vermont, who was charged with a felony offense for 2.1 ounces. In Bennington County, for example, the state’s attorney has come out publicly with her opinion that cannabis is a dangerous drug, it’s a gateway drug, and the only way to deal with it is strict law enforcement.

TG Branfalt: Law enforcement, when legalization happened, one of the things that we saw was the police chief’s association, or whatever it actually is, they were talking about what they wanted to see in the legalization law, and one of the things that they’ve really been pushing for, and I think this goes back even a little before legalization was rolling out this oral swab test to test for cannabis impairment, or intoxication.

So first, what are the baseline problems, if there are any, which we’re going to assume that there are, with this oral swab test?

Tim Fair: A baseline problems, the entire thing is a problem. The entire concept of having to worry about drugged driving and accurate tests is ridiculous. It’s just an issue that is used by prohibitionists to stoke fear, to get the average citizen against legalization.

I’ll try to keep this short, but when I talk about drugged driving, I need to talk about DUI. DUI is an example of a pre-crime. What I mean by that is you’re taking two legal activities, drinking alcohol, and driving a car, putting them together, and making it a crime. Not because anyone has been injured or anyone’s been hurt, but because we as a society have accepted the fact that the risk, the risk that is created by operating a motor vehicle under the influence of alcohol is so high that we are going to make it a crime because of what might happen, because you might be involved in an accident, because you might cause injury to yourself or others.

That risk is so greatly elevated, we have made it a crime. Now, let’s look at cannabis use. Because we have become so used to the idea of DUI and testing for alcohol, and legal limits, humans like patterns. They like things to make sense. So, therefore, there is this inherent belief that cannabis use will result in the exact same thing as alcohol use, when behind the wheel of the car. It’s not true. It’s simply not true.

The most recent National Highway Safety Administration study that I’ve seen has shown I believe a 5% increase in the likelihood of a serious auto accident with moderate cannabis use. That’s very subjective, what’s moderate cannabis use? But the point being that the human functions that cannabis impairs are very different from the functions that alcohol impairs.

Number one being the understanding of self. When somebody’s intoxicated on alcohol, they think they can drive real well. “I can drive, I can make it there. I’m the best driver in the world.” When somebody’s consuming cannabis, they don’t think they can drive well. They don’t think they can walk well. They say, “You know what? I’m going to sit right here on this couch for a little bit.”

The functioning that is affected by cannabis use is not the same as alcohol. We don’t need to make a new pre-crime. we don’t need to be able to test people to see if they’re impaired. If they’re impaired, they will drive outside of the law, they will commit violations, they will swerve, they will drive under the speed limit, they will run a stop sign. Law enforcement can observe that, pull them over, and arrest them.

Put them through the DRE, or Drug Recognition Expert protocol, and prosecute them. End of story. We don’t have such a high level of risk to warrant or necessitate some sort of test to establish impairment when there are no signs of impairment.

TG Branfalt: One of the things that they talk about in the literature that we saw when we were out at capital during the debate, are these per se intoxication standards. Can you explain what those per se intoxication standards mean and do they differ from the current alcohol laws?

Tim Fair: So they’re designed to mimic the current alcohol laws. We like legal limits. Above this, guilty. Below this, innocent. That’s not actually how it works, but that’s how most people accept it to work, and they like that consistency. It’s a very comforting idea to have, if you have over five nanograms of THC metabolized in your system, you’re above a per se limit. Doesn’t work. It doesn’t work, because cannabis is not alcohol.

People metabolize drugs differently, they metabolize cannabis differently, metabolites can stay in the human body in different levels for different amounts of time. It’s a fat soluble compound, therefore it can stay in the fat cells much longer than alcohol, and the presence of metabolites, the presence of whatever they’re testing for, does not correlate to impairment on any level.

One person with five nanograms could be at a very, very different functional state than somebody else with the exact same amount.

TG Branfalt: I want to talk to you more about Vermont policy, specifically this idea that we talked about when we first met, this decriminalization versus legalization premise. Before we do that, we’ve got to take a break. This is the Ganjapreneur.com Podcast, I’m TG Branfalt.


If you are looking for a job in the rapidly growing and highly competitive cannabis industry, Ganjapreneur.com is the place to look. Visit the Ganjapreneur job board today to browse current openings with cannabis companies throughout the United States. From entry level bud tender positions to executive level career opportunities. You can also create a profile and upload your resume to be discovered by cannabis recruiters. Visit our job board at jobs.ganjapreneur.com to create your profile today.

If you are a business owner, you can post your job openings for as little as $25 on our job board to reach the largest and most engaged audience of cannabis professionals on the web. Companies who are listed in the Ganjapreneur business directory are eligible for free job listings. If you’re already signed up, contact us today via the website or send us an email at grow@ganjapreneur.com to activate your unique coupon.


TG Branfalt: Hey welcome back. This is the Ganjapreneur.com Podcast. I’m your host, TG Branfalt, here with Tim Fair. He’s the owner of Vermont’s first cannabis law practice, Vermont Cannabis Solutions, and a guy I really like talking to since I’ve got to Vermont. When we first met, we were in the capital, it was during legalization law and we got talking about decriminalization versus legalization.

Vermont’s legalization law has been criticized by some as being a more broad decriminalization rather than legalization because there is no tax and regulate provisions under the laws passed, and signed by Governor Scott. They make this argument, despite Vermont actually decriminalizing cannabis possession five years ago.

For those people who make that argument, who criticize this law as not being full legalization, which I mean, we could talk about the nuances of full legalization, but let’s not do that. How does this legalization differ from decriminalization?

Tim Fair: You’re certainly right about it not being full legalization. Any sort of regulation is not full legalization. This is a step. Honestly, it’s more of a psychological step. As far as practicality, how this is going to impact your average citizen’s life, not much. Those who choose to consume cannabis do so now. Those who choose not to consume cannabis don’t.

What this is going to do is act as a psychological milestone for the industry as a whole. It’s going to serve to help kill the stigma. Normalization, getting the people who still believe the propaganda that this is a dangerous drug an opportunity to see that no, in fact, it’s not.

How it’s actually going to play out as far as legality, that’s a great question. After legalization, will the smell of cannabis still be sufficient for law enforcement to apply for a warrant to search your vehicle, to search your home? With the reasoning being, “Well, maybe it’s over the legal amount, and therefore might be a crime.”

With decriminalization, the legislature specifically stated that decriminalization did not change the fact that cannabis was contraband. Even though it was no longer a criminal offense, it was a civil violation, and still provided probable cause for law enforcement to then apply for a warrant to search your vehicle, to search your person, to search your home.

That I’m hoping will change. We’ve seen a lot more positive signs from the judiciary in Massachusetts. They’ve taken a much more liberal approach to it than the Vermont Supreme Court, but as far as actually practical changes, not a lot. It’s a step, though, and it’s an important step, because we wouldn’t be getting to tax and reg without it, and that’s where we’re eventually heading.

TG Branfalt: In Vermont, now we’re entering a whole new era, come July 1st. But we already have a small hemp industry, very CBD focused. In your role as a cannabis consultant, this is a smaller industry than other states, and we’re not talking about tax and reg right now. What does a cannabis consultant in Vermont do? What do you do working within this industry, and looking forward, are you already looking forward to tax and reg?

Tim Fair: A couple of questions rolled in there. No doubt. I’ll say that for the last year, majority of what I’ve been doing is learning and lobbying. Learning about much about the industry as I possibly can, learning about the areas of law in cannabis law that I have not practiced for the last five years, getting myself up to speed, and spending a lot of time in Montpelier, working with a lot of really, really good people and advocates, moving this agenda forward.

Trying to talk to legislators, trying to dissuade some of the apprehensions, to maybe dispel some of the myths. That’s what I’ve been doing for the last year. Right now, we are an interesting place. Vermont is unbelievably supportive of the hemp industry. The legislature went as far as to put a signing statement into the statute, reaffirming their support for the hemp industry.

I’m trying to think of the exact number. I don’t know if it’s 14 or 17 states that allow hemp growing at this point, and Vermont by far is the least regulated. $25 a year, you fill out a one page form, you get your card, and you can grow hemp, which is fantastic. We’re an agricultural economy here in Vermont, and this is the beginning of what I believe to be the rejuvenation of that economy.

TG Branfalt: When you’re talking to people right now who are in the hemp industry, are there a lot of questions right now, even several months before legalization takes effect, and possibly years before tax and reg, are people already trying to figure out what that industry could look like?

And the other thing is this. Do you think that it’s going to be more representative, it’s going to be similar to the hemp industry that we have here, which is primarily small farmers?

Tim Fair: That’s a great question. I think we have to wait and see. Regulations for Vermont’s taxed and regulated system are going to be coming out this year. There’s definitely a very, very strong desire to keep this as local as possible, to keep things on the Vermont scale, and one of the things about the cannabis industry right now is that it is extremely state specific.

So, it would be very difficult for somebody from out of state to come into Vermont, let’s say a large scale operation out of Colorado. They may know the Colorado regulations very well, they may know how to function and run their business under the Colorado regulations, they won’t know anything about Vermont. They won’t know anything about the Vermont regulations, so that factor helps keep it local.

I’m hoping that we are going to maintain accessibility for the average Vermonter. That’s what Vermont Cannabis Solutions is about. We’re not taking out of state clients, we’re working with Vermont small business and entrepreneurs who want to get involved in this industry. Whether the legislature will help that or hinder it, we have yet to see.

TG Branfalt: Speaking of the legislature, I mean, it’s the first in the nation to pass legalization via the legislature. It was cool to be here when that happened, but how long … You’ve spent a lot more time in Montpelier than I have. How long do you think the legislature’s going to let this gray market exist? I mean, we both hear things about donations and these things that are already happening in Massachusetts, and Massachusetts, to their credit, is allowing it to go on pretty much in the open. How long do you think that’s going to jive with the legislature, just watching the money fall out of their pockets?

Tim Fair: There’s two ways they can go. The gifting cannabis economy, we see it in D.C., we see it in Maine, we’re seeing it develop in Massachusetts. This is a function of going halfway. Legalization without a taxed and regulated system. I was having an email exchange with a former professor of mine at Vermont Law School the other day, and when you look at the statutes in Vermont, gifting is allowed. Gifting is allowed.

The statutes specifically state that it is illegal to sell quantities of cannabis under one ounce, but when you talk about distribution, it’s only addressed in quantities above one ounce. There’s noticeably lack of any mention of prohibition of distribution under an ounce. Meaning, you can give away up to an ounce perfectly legally. What does that lead to? That leads to the $100 Snickers bar that comes with a free quarter ounce, or in D.C., the juice bars that serve $50 glasses of orange juice with a free eighth.

It’s runarounds, it’s loopholes. It’s entrepreneurs looking at the system and figuring out how they can move forward with the framework as it is. I believe this is not going to last long. The two options the legislature has is A, they can go back and try to reconvene and pass a bill to close the loophole, which will take a whole session, or they can establish tax and regulation.

This year we will most likely be seeing Canada come online with it’s recreational program. We’ll be seeing Massachusetts come online, Maine hopefully after LePage gets out. People will be actually seeing functioning, well-functioning cannabis systems and once they’re seeing it with their own eyes, once they’re seeing all the gloom and doom predictions of the prohibitionists are not coming true, the sky is not falling, six year olds aren’t running around with joints, what they will see is a good functioning systems that are generating significant tax revenue. I think when people see that, tax and reg is inevitable.

TG Branfalt: I mean, it’s coming. I mean, briefly, I just want to talk to you very briefly, just before we started recording, we were looking at that lawsuit that’s happening on a federal level. I mean, at some point, right, the crest has got to come? I mean, New England is basically decriminalized throughout. All of Vermont’s borders, save for New Hampshire, right? No, New York, sorry, my bad. But I mean, New York, you look at New York, what have they got? Pennsylvania, that’s it. Jersey’s on its way. I just want to, just point out what we’re looking at from our perspective in Vermont, you know?

Tim Fair: Jersey is the East Coast key. Once Jersey goes, New York will go, and once New York goes, then we’ve got the East Coast. For me, it was California legalizing recreational. That was the point for me where I fully believed that the toothpaste can’t be put back in the tube. The genie ain’t getting back in the bottle, no matter what we see from the federal government. Once California estimated 6-7 billion dollar a year industry-

TG Branfalt: Which the whole industry did nine billion last year I think is the number.

Tim Fair: Yeah, with a B. That to me was the point of no return. But the federal government goes kicking and screaming. It’s very difficult to get anything done under the best of circumstances in Washington, and where we find ourselves now, I’ll just say are not the best of circumstances. That’s why another kind of benefit of the state specific nature of this industry that has allowed the states to really take it and run with it on their own.

Yes, inevitability. That’s a great word. The industry is inevitable. How long it’s going to take, how long we have the prohibitionists kicking and screaming. That’s impossible to tell right now.

TG Branfalt: So I want to get your advice for current operators and other people within Vermont’s market. Before we do that, we’ve got to take a last break. This is Ganjapreneur.com Podcast with TG Branfalt.


At Ganjapreneur, we have heard from dozens of cannabis business owners who have encountered the issue of cannabias, which is when a mainstream business, whether a landlord, bank, or some other provider of vital business services refuses to do business with them simply because of their association with cannabis. We have even stories of businesses being unable to provide health and life insurance for their employees because the insurance providers were too afraid to work with them.

We believe that this fear is totally unreasonable, and that cannabis business owners deserve access to the same services and resources that other businesses are afforded, that they should be able to hire consultation to help them follow the letter of the law in their business endeavors, and that they should be able to provide employee benefits without needing to compromise on the quality of coverage they can offer.

This is why we created the Ganjapreneur.com business service directory, a resource for cannabis professionals to find and connect with service providers who are cannabis friendly and who are actively seeking cannabis industry clients. If you are considering hiring a business consultant, lawyer, accountant, web designer, or any other ancillary service for your business, go to Ganjapreneur.com/businesses to browse hundreds of agencies, firms, and organizations who support cannabis legalization and who want to help you grow your business.

With so many options to choose from in each service category, you will be able to browse company profiles and do research on multiple companies in advance, so you can find the provider who is the best fit for your particular need. Our business service directory is intended to be a useful and well-maintained resource, which is why we individually vet each listing that is submitted.

If you are a business service provider who wants to work with cannabis clients, you may be a good fit for our service directory. Go to Ganjapreneur.com/businesses to create your profile and start connecting with cannabis entrepreneurs today.


TG Branfalt: Hey welcome back to the Ganjapreneur.com Podcast. I’m your host, TG Branfalt, here with Tim Fair, owner of Vermont’s first cannabis law practice, Vermont Cannabis Solutions, and kindred spirit, especially when it comes to the sole federal government issue. So, I wanted to ask you, your advice for current operators in Vermont. That’s what you focus on, that’s where we are. Do you think that those who are focused on hemp right now have a slight headstart as we inch towards tax and reg?

Tim Fair: Absolutely. I mean, there’s no question about it. They’re getting the experience in the industry, they’re getting the experience, whether it’s growing the crop, whether it’s extracting whether it’s selling. Whatever people are doing, they’re getting that experience now. As far as non-hemp cannabis, higher THC level cannabis, that’s limited really right now to our medical dispensaries.

The average entrepreneur’s not having that opportunity, so the people right now who are in the hemp and CBD, yeah, they’re getting a headstart. The question is are they all going to want to transition into cannabis? Some yes, some no. But that doesn’t mean that there aren’t steps that can be taken right now for those who want to get into the legal cannabis market. Whether it’s recreational or medicinal.

TG Branfalt: Earlier you said that you think it’s going to be harder for out of state people to enter the Vermont market. If people wanted to start looking at that market now, what would advice be for those who are or might be interested in entering Vermont’s market when it starts to become established?

Tim Fair: You mean people from out of state who might want to come in?

TG Branfalt: Yeah, yeah.

Tim Fair: Learn the Vermont way. Learn Vermont.

TG Branfalt: It’s tough. I mean, neither one of us are from Vermont.

Tim Fair: No, no, absolutely. Growing up in New York City, it blew my mind here. But Vermont is a lot more about who you are. It’s about face to face connections. It’s about knowing people. In order to succeed in the Vermont market, especially at this point in time, who you know, the impression you’ve made on people, the reputation that you have within the cannabis community here in the state, that is going to carry a lot more weight than what you’ve done somewhere else, or how much money you may have.

It really comes down to knowing each other, and if somebody from out of state had a real serious interest in coming into Vermont, come to Vermont. Come to some events. Come to some lobbying events. Meet people in the community. We’re a small state, we’re a relatively small community, and it’s very accepting.

The thing people don’t want to do is just simply come in and try to buy their way into the industry. That’s just not really going to work here in Vermont.

TG Branfalt: You’ve had your own interesting path to sit in this chair, talking about cannabis, lawyer. What’s your advice for other entrepreneurs who are seeking to enter the cannabis space? Just people who may not be in this industry now.

Tim Fair: Know why you want to get into the industry. If the answer is, “Because I think I’m going to make a bunch of money,” pick another industry. Know why you want to get into it. Once you’ve figured out why you want to get into it, my next piece of advice is learn the industry. It’s not simply about hanging around and getting stoned all day, and growing some pot.

This is a growing industry. When you factor in the CBD, industrial hemp, all of the uses, the sitting around, getting stoned, a piece of the pie. But there’s a lot more to the industry than that. The nuances of the industry, what has happened over the last five years in Colorado and California, in Oregon, in Washington, in Alaska. These are lessons that can be learned. These are real lessons. Some of them will be applicable to Vermont, some of them will not.

But by studying the industry, by seeing the problems and how they’ve been dealt with, it’s going to be the best way to have a realistic expectation of one’s experience here in Vermont in the industry.

TG Branfalt: I mean, this has been really cool, man. Like, I’m stoked to have you on the show. I mean, when we met in Montpelier, we both looked at each other like, “All right, I got you. I got you.” Where can people find out more about what you’re doing with the Vermont Cannabis Solutions, find out more about you? Plug it up, man.

Tim Fair: I’m not real good at self-promotion or plugs. I’ll say the website, www.VermontCannabisSolutions.com, is my first attempt at a website, so take it easy on me. But it’s got a lot of contact information, talks a lot about what we’re trying to do here in Vermont. Other than that, tfair@bwvlaw.com. Shoot me an email, happy to chat with anyone, anytime.

TG Branfalt: Dude, I really, again, I appreciate it, and I’m sure we’ll be sitting in these chairs chatting in a few months when legalization’s getting close, man. I appreciate it again.

Tim Fair: I certainly hope so, TG. I appreciate it, my man.

TG Branfalt: You can find more episodes of the Ganjapreneur.com Podcast in the podcast section of Ganjapreneur.com, and in the Apple iTunes Store. On the Ganjapreneur.com website, you will find the latest cannabis news and cannabis jobs updated daily, along with transcripts of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. This episode was engineered by Trim Media House. I’ve been your host, TG Branfalt.

End


Indoor cannabis plants under the pink-hued glow of LED grow lights.

Study: Cannabis Legalization ‘Not the Cause’ for Pueblo County, Colorado Crime and Homeless Challenges

a word from our sponsors:

advertisement

advertise here

According to researchers at Colorado State University-Pueblo’s Institute of Cannabis Research, legalization is not the cause of many of Pueblo County’s recent challenges, Colorado Public Radio reports in an outline of the study. In fact, cannabis sales led to $35 million for the region in 2016, after factoring in costs for enforcement.

Legalization is often cited as a factor in the increased number of homeless people in Pueblo. However, ICR sociologist Timothy McGettigan said that the increase in the number of homeless people in the city is more likely due to increased housing and utility costs.

“The idea that people have been coming to Colorado from out of state in droves, spending their last dime on cannabis and then lining up at soup kitchen queues and at social service agencies is not really accurate. The picture is much different than that.” – McGettigan to CPR

ICR Director Rick Kreminski suggested that the increase in crime in Pueblo since legalization is more likely attributable to the population increase, the decrease in law enforcement officers and the “lack of clarity on some on the marijuana laws.”

The study was split into three sections: social impact (demographics, poverty and homelessness, student use and prevention, crime, health); economic impact and prediction; and water and energy impact.

Social Impact

  • “The population characteristics have remained unchanged … population has increased … but the rate of population increase has remained roughly unchaged.”
  • “No direct quantifiable evidence” to support the notion that the city has been “inundated by migrants.”
  • “Out-of-state migrants to Colorado generally bring college degrees, experience and affluence that enriches Colorado.”
  • “Legal cannabis has not yet had an observable impact on Pueblo’s household incomes. It is possible that the enduring federal prohibition shrouds the true impact of legal cannabis on Pueblo’s household incomes. This is a phenomenon that requires more investigation.”
  • “Poverty rates have neither increased nor decreased. … Pueblo has experienced substantial increases to homelessness” but there is “no clear evidence to unambiguously determine the extent” to which cannabis legalization has attributed to that increase.
  • “It is possible that the largest source of homelessness in Pueblo may be attributable to utility costs. In 2016 alone, a local energy provider was reported to have disconnected utilities to more than 7,000 Pueblo homes.”
  • Cannabis legalization “has not greatly affected high school student use and perceptions towards cannabis in south central Colorado.”
  • Nearly half of the region’s middle and high schools do not provide cannabis prevention education.
  • Crime has increased but cannabis seizures in the city itself are down; although they are up in the county “likely due to the larger volume of illegal marijuana grown present in the county.”
  • The largest crime increase has been property crimes – particularly motor vehicle theft – and danger drug seizures – particularly heroin.
  • Violent crime in the city is up “marginally” but down throughout the county.

Health

  • No “statistically significant change” among women who use cannabis in the county post-legalization.
  • Individuals testing positive for cannabis at hospitals has increased 3 percent.
  • Legal cannabis is complicating the Pueblo County Department of Social Services work with families but “it’s impossible to draw any conclusion about the influence of legal cannabis. … One one hand caregivers appear to be more open and honest about their use of cannabis, but also less likely to comply with court orders to stop using due to the legal status of cannabis in Colorado. This leads to stress in the relationship between caseworkers and caregivers, which could reduce the effectiveness of services provided.”

Economic Impact

  • Real estate values, per capital income, and construction spending in Pueblo is higher post legalization but that could be attributed to the positive national economy.
  • Prices will drop over the next five years and that drop will “have some effect on tax revenue.”

Water and Energy Usage

  • The industry is “very far” from utilizing best practices but “water and energy use is likely to fall” as “growers learn what works.”

The study is the first of its kind. It was paid for largely by local and state cannabis taxes.

End


Sonoma County, California DA Taking ‘Proactive’ Approach to Addressing Cannabis Convictions under New Law

a word from our sponsors:

advertisement

advertise here

The Sonoma County, California district attorney’s office will “proactively” search for cannabis convictions eligible for reduction or dismissal under the Medicinal and Adult-Use Cannabis Regulation Safety Act. District Attorney Jill Ravich indicated that there have been “dozens” of convictions already reduced and dismissed but estimated there is still about 3,000 more that have not been acted upon.

“With Proposition 64 California voters clearly indicated their intent to offer people convicted of cannabis related offenses to have their records cleared. Further, the state legislature is currently contemplating legislation that would pave the way for the automatic expungement or reduction of cannabis related convictions. Therefore, my goal is to do whatever I can within the resources at my disposal to be consistent with this intent.” – Ravich in a press release

How does it work? The office has set up a website for citizens to determine whether their cannabis-related case is subject to any reduction or dismissal under the law. The district attorney’s office is working with cannabis consultants 421 Group and attorney Omar Figueroa in the process.

Almeda County District Attorney Nancy O’Malley and San Francisco District Attorney George Gascón have each also announced that their offices would take a proactive approach to dismissing or reducing cannabis crimes under the state law.

End


Colorado Considering Bill to Let School Nurses Provide MMJ to Students

a word from our sponsors:

advertisement

advertise here

Colorado’s Legislature is considering a bill to allow school nurses to administer medical cannabis to students registered with the state program, according to a KDVR report. The measure, called “Quintin’s Amendment” would be added to “Jack’s Law” which allows students to use medical cannabis in schools.

The bill is sponsored by Democratic Rep. Dylan Roberts and would allow school nurses to administer non-smokable forms of medical cannabis.

“A lot of times these kids, either because of their age or because of their condition, can’t administer the medical marijuana to themselves so they need somebody to do it for them.” – Roberts to KDVR

Hannah Lovato, the mother of Quintin Lovato for whom the bill is named, said that the third-grader requires three doses per day but, due to the family’s schedule, he is only getting two doses per day and his seizures persist.

“If a nurse was able to give him that third dose at school, that would open up his medication doses and help us out immensely. And it may mean the difference between where he’s almost seizure free right now and actually being seizure free if he was able to get that third dose.” – Hannah Lovato to KDVR

The measure is currently in the House Health, Insurance and Environment Committee. It’s expected to get heard by that committee March 29.

End


MMJ Research Firm Secures Production License from Health Canada; One Step Closer to FDA Approval

a word from our sponsors:

advertisement

advertise here

MMJ Bioscience is in the process of securing orphan drug status from the U.S. Food & Drug Administration for MMJ 001, a CBD derivative, for use as a multiple sclerosis therapy. The company has secured a Health Canada license to produce cannabis for medical purposes to extract active ingredients from cannabis to manufacture gelcaps and has filed an application to begin FDA-approved clinical trials.

“MMJ BioScience also plans to repeat that accomplishment for MMJ-102 for Huntington’s disease. The FDA’s granting of orphan designation for multiple sclerosis is a key step toward that goal. These are debilitating diseases that need new and more innovative treatments, and we look forward to working with the FDA to begin clinical trials to fully explore the potential of cannabis medicines.” – Tim Moynahan, MMJ Bioscience chairman, in a press release

What’s an orphan drug? The FDA grants orphan drug status to drugs and biologics that affected fewer than 200,000 people in the U.S. Orphan drug designation includes benefits such as seven-year marketing exclusivity against competition, federal grants, and tax credits for qualifying clinical trials.

MMJ Bioscience is an affiliate of MMJ International Holdings. The company first filed the new drug application with the FDA in January.

End


Indiana Lawmakers Turn CBD Bill into Guns Bill

a word from our sponsors:

advertisement

advertise here

Lawmakers in Indiana have used a “strip and replace” procedure to turn CBD legislation to gun legislation as the state’s session winds to a close, according to a WTHR13 report. The gun bill would allow state citizens to obtain a lifetime handgun permit for free and allow members at churches with schools to carry firearms to church events.

The bill sponsor, Rep. Bill Friend, told WTHR that the bill had become a vehicle and no longer has “anything to do with CBD oil.” The CBD measure was approved unanimously by the House in January and passed the Senate with a 3-to-1 margin. All that was left was for the chambers to come together for a conference and work out some of the differences between the House and Senate versions.

Another bill to legalize CBD oil in the state still lives in the state Senate – which is why lawmakers were able to completely gut the bill that has already had success in both chambers; they only need one bill to legalize CBD. The measure that still exists is the one approved by the House before moving to the Senate, becoming a Senate version and being turned into a vehicle bill for guns.

The Indiana Session closes in two days.

End


Photograph of the view looking down the row of flags at the United Nations office in Geneva.

UN Report Calls Out Nations for Cannabis Legalization

a word from our sponsors:

advertisement

advertise here

In their 2017 annual report, the United Nations International Narcotics Control Board called out Uruguay, the Netherlands, Jamaica, Canada, and U.S. states for implementing or moving forward with cannabis legalization.

“The Board wishes to reiterate that any measures that permit or would permit the use of cannabis for non-medical purposes are in clear violation of article 4, paragraph (c), and article 36 of the 1961 Convention as amended, and article 3, paragraph 1 (a), of the 1988 Convention. INCB also reiterates that the limitation of the use of controlled substances to medical and scientific purposes is a fundamental principle to which no derogation is permitted by the 1961 Convention as amended.” – U.N. INCB, 2017 annual report

The report notes that as of Jan. 2017, Uruguay had registered 6,057 individual cannabis cultivators and 33 members’ clubs which allow groups of 15 to 45 people to cultivate and distribute cannabis for the group. The report indicates that Uruguayan officials plan to assess the public health consequences of legalization and issue a report to the INCB; however, in the report the board “reiterates that the legalization and regulation of cannabis for non-medical purposes is contrary to the relevant international legal framework, which categorically restricts the use of controlled substances such as cannabis to medical and scientific purposes.”

The report also takes aim at the famous coffeeshops in the Netherlands; which, despite being the subject of reforms by lawmakers – hoping to make them exclusive to citizens of the Netherlands – still violate United Nations drug treaties.

The U.N. conventions do allow medical and scientific cannabis use; although the report does note that governments with medical cannabis programs should not allow for home-growing by patients.

“States must take measures to prohibit the unauthorized cultivation of cannabis plants, to seize and destroy illicit crops, and to prevent the misuse of and trafficking in cannabis. Similarly, the Board wishes to draw the attention of all Governments to its previously stated position that personal cultivation of cannabis for medical purposes is inconsistent with the 1961 Convention as amended because, inter alia, it heightens the risk of diversion.” – U.N. INCB, 2017 annual report

The U.S. could bring members states with legalized cannabis regimes before the International Court of Justice.

(h/t Leafly)

End


A cannabis worker wearing blue gloves pours concentrate product out of a pot and onto a parchment paper-covered baking sheet.

Virginia Gov. Signs ‘Let Doctors Decide’ MMJ Measure

a word from our sponsors:

advertisement

advertise here

Virginia Gov. Ralph Northam has signed the legislation allowing physicians to recommend medical cannabis oil for any condition as long as they decide it’s the best course of action for the patient, according to a WVTF report. The law expands the state program from a qualified condition list to a model that allows doctors to do what they believe is best for the patient.

Patients, however, are still waiting for the state to license its first medical cannabis facilities, which the head of the Roanoke Valley Chapter of NORML, Katie Clifton, said would take about two years. Lawmakers approved five medical cannabis facilities last year.

“The applications will be released, then there will be time for the people who are interested to apply for those applications, then you have actually have to build to the facility, which will be a seed to sale facility. You have to grow it, you have to process it, then you have to sell it. So it’s a very large project.” – Clifton to WVTF

The law also allows physicians to provide patients with a certificate they could give law enforcement if they are found in possession of the oil. The state law allows patients to access either CBD or THC-A oil but does not provide for flower products. The expansion was unanimously approved by both chambers of the state legislature.

End


Business partners working together at a table on laptops.

Weedmaps Responds to California Regulators’ Cease-and-Desist Request

a word from our sponsors:

advertisement

advertise here

Weedmaps has responded to the California Bureau of Cannabis Control’s cease-and-desist request to stop advertising unlicensed dispensaries in their cannabis dispensary mapping site, the Sacramento Bee reports. In a letter to the agency, Weedmaps says its advertisers “represent and warrant that they are in compliance with local law” and that those individual companies are responsible, rather than Weedmaps.

Weedmaps also argues that many of the unlicensed businesses are protected under state law until next January because they are cannabis cooperatives and the state’s old medical cannabis laws allows such non-profit entities until the new law’s sunset clause takes effect. In the letter, Weedmaps argues that these businesses would likely seek licenses but the “regulatory landscape is so blurry it stifles investment.” According to the report, about 85 percent of the Golden State does not allow recreational cannabis sales due to local bans on the industry.

California cannabis regulators argued that by allowing unlicensed companies to advertise on the site, Weedmaps is “engaging in activity that violates state cannabis laws.” Sacramento cannabis policy chief Joe Devlin argued that the groups advertising on the site are not nonprofit, evidenced by the fact that they are advertising on the site.

Following the letter to Weedmaps, BCC spokesman Alex Traverso told the Orange County Register that there was “no immediate action planned” against the company.

End


View of the solar panels and organic garden at Happy Day Farm in Mendocino Conuty, California.

Review: HappyDay Farms, Mendocino, CA

a word from our sponsors:

advertisement

advertise here

In these days of growing industrialization in our beloved cannabis industry, it is heartening to find a farm holding steady to the high ideals of community commerce and environmental stewardship. Casey and Amber O’Neil are the proprietors of HappyDay Farms, an artisan food, flowers and cannabis farm in Mendocino County, CA. HappyDay intermingles cannabis and food crops as companion plants while adhering to permaculture and other holistic growing principles. While many poseurs slap the “beyond organic” description onto their products, this is truly the case on Casey and Amber’s farm.

I asked Casey in what ways they integrate these vital probiotic growing techniques.

“We consider ourselves holistic farmers. Trying to look at the farm as a whole organism, we try to sequester carbon by building pasture and incorporating cover crop rotations. We store rainwater, brew teas from farm compost, and are excited to begin making fermented plant juice teas this year with comfrey, alfalfa, horsetail and other plants we will harvest on-farm.  We’re big believers in providing food for soil biota through cover crops, compost, companion plantings and maintaining wild spaces for native habitat, beneficial insects and pollinators. Creating a thriving, regenerative farmscape is of utmost importance to us.”

The Ganjapreneur review team was able to enjoy HappyDay Farms’ cultivars “Sour Strawberry,” “Ogre Berry,” “Chem Valley x OG Strawberry,” and “Ogre Berry x OG Strawberry.” You can taste all the extra effort in HappyDay flowers.

Flowers from HappyDay don’t have the glossy centerfold look of the most extreme indoor crops, but these award-winning flowers drip with the sacred beauty of the plant at its happiest — outdoors in the California sunshine. Their flowers are gentle and brilliant and patiently urgent. They are a pleasure to look at and handle and they give you a great high without any suspicion of them containing synthetic nutrients. Knowing that your cannabis is so clean really increases the enjoyment of their flower by adding peace of mind to your “set and setting.” This is a level of confidence in flower truly for connoisseurs. To drive that point home, HappyDay Farms is Clean Green Certified.

Brand licensing has become a huge part of the cannabis industry. Many of the popular brands simply purchase cannabis from producers, slap their name on it and now they say it is their “craft” product. Be clear about this. Growers like HappyDay Farms are entirely the reason that there is a “craft cannabis” category: smaller runs, bigger hearts, extra servings of nature-loving care in growing flowers for you. True craft.

“Asking folks if they like ‘Fruitys or Fuelys’ at the farmer’s market is an opening icebreaker,” said Casey. “About a third of the time, the person will answer either ‘fruity’ or ‘fuely.’ About two-thirds of the time they say, “What?” This gives me the opportunity to talk about the different scents and flavors present in the various strains. I note that most of what we do falls into the “fruitroleum” category, but that we have defining cultivars in each direction. While they are smelling the jars, I let them know that they are welcome to sample, and I describe the effects of the various offerings.”

This kind of personalized farmer contact and down-home vibe is being threatened by the new regulatory structure — but, at the same time, the new, “more legal” licensed market will allow for distribution never seen in the days of Prop 215 medical and is probably the only reason you might find HappyDay flowers outside of their immediate locale. There will likely not be much long-term middle ground. The Prop 64 licensed cannabis industry will either offer much-needed sustainability and regularity to California’s artisan cannabis community or it will plunge California into a morass of corporatized cannabis fighting against long-time heritage cannabis growers on every level.

Casey and Amber O’Neil of HappyDay Farms offer sustenance at a local farmers market. Photo credit: HappyDay Farms

Leaving Casey and Amber’s farm ends with a bit of fun as they cheer “Great Success!” in parting.

It’s a constant saying on the farm, we started printing it on stickers and t-shirts in 2012 and in 2016 we entered a strain of ours in the Emerald Cup and gave it the name Great Success and it won 11th place.  It sorta captures what we’re all about, my Grandfather always said: “Let us be happy in our work” and we strive to maintain an upbeat positivity. Good energy is cyclical and creates positive feedback loops, and “Great Success” exemplifies that potential. Words have power and we strive to always create the best possible interactions and processes that we can.”

HappyDay Farms is distributed in California by Flow Kana in beautiful glass jars, so ask your local shop if they carry these wonderful flowers. Check out the HappyDay Farms website for more info, or visit their Instagram or Facebook to get in touch!

End


Report: Federally Legal U.S. Cannabis Industry Could Create 1.1M Jobs by 2025

a word from our sponsors:

advertisement

advertise here

According to a New Frontier Data report, if the U.S. government were to legalize recreational cannabis, the industry could infuse the national economy to a tune of $18.9 billion by 2025, based on a 15 percent tax rate. The report estimates that sales taxes, if implemented federally at 15 percent, could reach $51.7 billion. The revenues would be entirely new revenue for the U.S. Treasury as there are currently no federal sales or excise taxes.

The analysts estimate that federal legalization could create 782,000 jobs almost immediately and 1.1 million by 2025, which would represent $4 billion in payroll taxes in the early days of the industry, and as much as $5.9 billion by 2025.

“By combining the business tax revenues, the payroll withholdings based on the theoretical employment required to support the industry, and the 15 (percent) retail sales tax, one can calculate the total federal tax revenue potential of legalization: The combined total is estimated to be $131.8 billion. The difference between the current structure and the theoretical model is a $76.8 billion increase in federal tax revenues.” – New Frontier Data report, “Cannabis in the U.S. Economy: Jobs, Growth & Tax Revenue, 2017 Edition.”

The report notes that the report was prepared prior to the Tax Cuts and Jobs Act signed into law by President Donald Trump in December.

End


Timeline for Canadian Legalization Gets Murky as Senate Pushes for Drugged Driving Bill

a word from our sponsors:

advertisement

advertise here

The Canadian Senate is effectively stalling federal cannabis legalization as they push for drugged-driving legislation, according to a report from Investor Intel. According to their analysis of the situation, December 2018 would be the earliest legalization could occur and the chamber could delay the legislation to the next election, which would effectively kill both the legalization and drugged driving bills.

What’s the timeline look like?

While the Senate has already held hearings on the legalization measure, it has not gone line-by-line through the analysis to see how it jives with existing laws. According to the report, it likely won’t begin that process until May, after the chamber finished with the drugged-driving bill, putting the timeframe in which it would move back to the House of Commons for third reading to June.

Part of the drugged driving legislation includes a six-month period to allow law enforcement agencies to catch up – so if the legislation passes in June, legalization would probably not be considered until at least December. The report notes that the Senate could continue delaying the legislation through Parliamentary procedures in order to prevent the bills from gaining any more traction until the next election – which, depending on the outcome, could derail Canada‘s legalization entirely.

End


Former Alabama Senator Jeff Sessions, current Attorney General, is notoriously anti-cannabis.

Sessions: Feds Focusing on High-Level Cannabis Dealers, Not ‘Routine’ Cases

a word from our sponsors:

advertisement

advertise here

During remarks to the Federalist Society in Washington D.C., Attorney General Jeff Sessions admitted that the federal government does not have the resources to investigate and prosecute “routine” cannabis cases and would instead focus on gangs and other high-level illicit dealers, according to a CBS News report. Sessions added that the federal prosecutors “haven’t been working small marijuana cases before and … are not going to be working them now.”

The comments come about three months after Sessions rescinded the Obama-era Cole memo which protected state-approved cannabis businesses from federal interference. Sessions seemed to explain his decision to cancel that directive during his speech, saying that he is “not going to tell Colorado or California or someone else that marijuana is legal under United States law.”

Sessions explained that some of the issues the federal government is worried about in legal state – such as diversion and illegal cannabis growing operations – would be handled at the discretion of the individual states’ U.S. attorneys.

President Donald Trump has, on at least two occasions, indicated that he would support the death penalty for drug dealers; although, those comments have typically come in speeches focused on the opioid epidemic rather than cannabis policy.

End


West Virginia Fails to Pass MMJ Reforms

a word from our sponsors:

advertisement

advertise here

The West Virginia Legislature failed to pass legislation to increase the number of medical cannabis licenses and open the door to patients accessing flower products, according to a WVNews report. The bill, which passed the House late last month, was heavily amended by the Senate and was unable to make it back to the House floor for a vote before the legislative session ended.

The measure that passed the House included:

  • Cannabis decriminalization.
  • Medical cannabis home deliveries.
  • Instructing the Bureau of Public Health to create a rule allowing flow products to be included in the state medical cannabis regime. That rule would have still needed to be codified by the legislature before becoming law.
  • Requiring the bureau to issue permits for up to 100 dispensaries

In amending the measure, the Senate removed the decriminalization, delivery, and flower language entirely, and reduced the number of dispensary permits to 50. The amended version, which included vertical integration – allowing companies to be cultivators, processors, and dispensaries – passed the Senate 26-7.

State Treasurer John Perdue has his own concerns about medical cannabis monies due to federal policy.

In a Mar. 1 letter, Perdue worried that the state-licensed cannabis businesses and the state’s banks could be opening themselves up to federal prosecution.

“Simply stated, all banks are subject to federal law, whether the bank is a state-chartered bank or a national bank. Because cannabis (marijuana) is an illegal drug under the Controlled Substance Act, financial institutions could potentially be violating federal law by accepting money derived from the cannabis industry, even if authorized by state law.” – Perdue, in a letter, via WVNews

Worth noting: When Jeff Sessions rescinded the Cole Memo he, reportedly, did not confer the decision with regulators at the federal Financial Crimes Enforcement Network, who at the end of September 2017 had reported that some 400 financial institutions were offering services to cannabis industry operators.

End


Arizona House Agriculture Committee Approves Industrial Hemp Bill

a word from our sponsors:

advertisement

advertise here

Arizona’s House Land, Agriculture and Rural Areas Committee has approved a measure to legalize industrial hemp cultivation in the state, according to a report from Arizona Public Media. The measure has already been approved by the Senate.

Sen. Sonny Borrelli, the Republican bill sponsor, indicated the measure would help boost the state’s agricultural economy, noting that hemp uses “nine times less water than cotton,” and help the state’s cotton farmers “rotate in another crop.”

“This is rope. It’s not dope. You can smoke a whole bale of this stuff. You are not going to get high on it.” – Borrelli, to AZPM

The measure caps THC content on industrial hemp crops at 0.3 percent – in line with federal definitions – and creates a licensing system for prospective growers, including background checks and fingerprints. The measure does not specify the fee amounts; however, the Department of Agriculture is seeking $750,000 and three full-time positions to create the rules and oversee the program.

Several states have moved on hemp legislation so far this year. In January, the Missouri Senate Agriculture, Food Production, and Outdoor Resources Committee heard testimony on hemp legalization legislation; and last month Alaska, Kansas, and Indiana progressed measure to implement hemp productions laws. Earlier this week, Oklahoma’s House approved an industrial hemp bill, and the Oregon Legislature reclassified hemp as an agricultural product to help jumpstart the industry.

End


An aerial view of the West Virginia State Capitol Building.

West Virginia Senate Committee Approves MMJ Bill; Could Allow Flower Access

a word from our sponsors:

advertisement

advertise here

A bill approved by the West Virginia Senate Judiciary Committee would require the state Office of Medical Cannabis to create a rule allowing flower products to be available under the state’s medical cannabis program, but the Legislature would still need to approve the rule, the Charleston Gazette-Mail reports. The law comes after the Medical Cannabis Advisory Board asked lawmakers to approve adding flower to the state regime.

The measure would also allow the state treasurer to create a credit union for the state’s canna-businesses and allow for vertical integration in the space – meaning businesses could act as any combination of cultivator, processor, and dispenser. The bill would also add osteopathic physicians to the cannabis board.

The bill passed the state’s House of Delegates earlier this month.

What else does the bill do?

  • Increases the number of permits the Bureau of Public Health can issue from 10 each for growers and processors to 50, and the number of dispensary permits from 30 to 165.
  • Changes patient certification provisions to allow medical professionals to determine whether a past or current medical condition could be a contradiction from medical cannabis use and includes language to determine if a patient is experiencing “serious pathophysiological discomfort, disability or dysfunction that may be attributable to a serious medical condition and may possibly benefit from cannabis treatment.”

If approved, the law would allow patients to pre-register with the medical cannabis program before it’s slated to come online in July 2019.

End


Photo of the city skyline for Detroit -- Michigan's largest city.

Michigan Attorney General Candidate Will Support Rec. Cannabis Ballot Initiative

a word from our sponsors:

advertisement

advertise here

A Democratic candidate for Michigan attorney general Pat Miles has thrown his support behind legalizing cannabis in the state, telling the Detroit News that he would support the reforms if they make the ballot and declaring the war on drugs a failure.

“The classification of marijuana as a Schedule I drug is ridiculous, and has done a great deal of harm to communities in our state and around the country, particularly communities of color.” – Miles, in a statement, via the News

Miles, a former U.S. attorney from Grand Rapids, had previously said he would only enforce any law the voters approved; however, his opponent Dana Nessel has been outspoken in her support of cannabis law reforms. She contends that Miles is only changing his stance now to score political points.

“I stated my unequivocal support for legalizing recreational marijuana the day I launched my campaign. I’ve never needed to evolve my position to meet what recent polling showed to be politically expedient.” – Nessel, in a statement, to the News

The state Democratic party is planning to endorse its candidates Apr. 15 and will formally nominate an attorney general candidate in August.

Legalization is popular in the Great Lakes State. An EPIC-MRA poll commissioned by Michigan NORML earlier this month found 61 percent support for the ballot question among Michigan voters. In November, the Michigan Coalition to Regulate Marijuana Like Alcohol submitted more than 365,000 signatures to state officials to put the issue to voters in November.

End


A flat layout of a business person's work station.

Cannabis Tech Companies BioTrackTHC and Helix TCS Announce Merger

a word from our sponsors:

advertisement

advertise here

Cannabis technology companies BioTrackTHC and Helix TCS, Inc., have announced they will merge – and while they will operate independently, the companies will “rationalize common business functions.”

BioTrackTHC is one of the largest providers of seed-to-sale technology in the cannabis space, providing its software to nine governments, along with inventory management and point-of-sale solutions to more than 2,200 licensed cannabis operators in 29 states and five countries. Helix provides proprietary software to legal canna-businesses and security, including transportation, armed and unarmed guard training, and investigations.

Patrick Vo will continue in his role as CEO of BioTrackTHC, and Zachary L. Venegas will remain as CEO of Helix and become the executive chairman of the board.

“After a very lengthy and competitive process, we have agreed terms with the company and major shareholders, and have signed a definitive agreement, creating the largest ancillary cannabis company in the industry. The combined firm will offer industry-leading services to clients, improving their ability to serve their customers while increasing efficiency and profitability.” – Venegas, in a press release

“We are confident that this merger will enable the combined companies to accelerate growth and thereby enhance the value of our products and services to the customers who rely on us. With the continued expansion and maturation of the cannabis industry, we are in an ideal position to rapidly adapt with the evolving needs of our clients.” – Vo, in a statement

In 2016, Helix acquired the cannabis industry’s oldest electronic marketplace Cannabase. Venegas said the “synergies between Cannabase and BioTrackTHC are significant.”

End


Emma Chasen: Educating the World About Cannabis Science

a word from our sponsors:

advertisement

advertise here

Emma Chasen is the Director of Education for Sativa Science Club, an organization that encourages industry-wide quality standards. She also, in 2016, received the Willamette Week‘s Portland, Oregon Best Budtender award.

In this Ganjapreneur.com podcast episode, Emma joined our host TG Branfalt for a conversation about the creation process behind her educational courses for individuals seeking careers in the cannabis space and why she thinks the cannabis industry should move away from the indica/sativa binary of categorizing cannabis cultivars. The interview also covers how she became a budtender for Farma (a Portland, Oregon-based dispensary that emphasizes a scientific definition and understanding of cannabis), her rise through the ranks of the cannabis space to eventually become the dispensary’s general manager, and what advice she would offer to somebody who is working in — or interested in — the retail side of the cannabis industry.

Tune in to the interview via the player below, or scroll down to read a full transcript of this week’s Ganjapreneur.com podcast episode!


Listen to the podcast:


Read the transcript:

TG Branfalt: Hey there. I’m your host TG Branfalt. You’re listening to the Ganjapreneur.com podcast, where we try to bring you actionable information and normalize cannabis through stories of ganjapreneurs, activists and industry stakeholders. Today I’m delighted to be joined by Emma Chasen. She is a cannabis science educator and consultant for the Sativa Science Club. She’s had a really interesting path to the cannabis space. She began it sort of at Brown University and in 2016, in her role at Farma she was named Portland, Oregon’s Best Budtender, but I’m going to let her tell that story myself — how are you doing this afternoon Emma?

Emma Chasen: I’m doing great TG. Thanks so much for having me.

TG Branfalt: Absolutely thrilled. I briefly sort of gave away a little bit about your background, but why don’t you tell us the story, how did you end up Portland, Oregon’s Best Budtender?

Emma Chasen: Sure. It was definitely a bit of a windy road. I did graduate from Brown University in 2014 with a specialized degree, biology degree. Part of what makes Brown so cool and wonderful is that they really let you do whatever you want. I was able to devise my own track within the biology program to really study medicinal plant research and ethnobotany. So, the way in which indigenous peoples have used medicinal plants over centuries and centuries. I came out of Brown not really sure about what I wanted to do. I was considering going the naturopathic route. So, becoming a naturopathic doctor, but I definitely did not want to jump into another five years of schooling. So, I took a job at Brown University Oncology Research Group where I was helping to coordinate Clinical Oncology trials nationwide and I naively thought that that was going to be my point of impact.

Because this was 2014, 2015. So, the cannabis movement was just starting to gain traction. Of course, it had been growing out here for a while, but out on the East Coast it’s a different story, different culture. I was excited that there was a little bit of momentum, especially in Rhode Island medical marijuana had passed. So, I thought, “Okay, maybe we can do some cannabis trials. That would be awesome and super cool.” Lo and behold, there was actually a brilliant professor from Brown who did propose a cannabis trial to my supervisor at the time and she did not even give him the time of day. She just laughed him out of the office and that was kind of the straw that broke the camel’s back for me in terms of just being done with that job.

I saw how much the cancer industry … how much money the cancer industry makes for one and just how much it profits off of people being sick. I was really disillusioned with that and came out of that job, moved back home to New York for the summer, because I’m from New York and just like, you know what, I need a new adventure in my life and so I packed up my car and drove across the country to Portland, Oregon, not even knowing if I wanted to get into the cannabis space, just knowing that there was more opportunity out here for the holistic medicine industry and jobs, but it was perfect timing, really synchronistic in that cannabis was just becoming legal for adult use. So anybody 21+ could start buying cannabis in October of 2015 and I got to Portland September of 2015.

So, everybody in the cannabis industry was hiring to prepare for this and I also, very luckily, found my way to Farma, which is a very popular dispensary in Portland that takes a more scientific to cannabis and at first I was like, “You know what, I don’t want to work in retail weed. I want to work in research or science or something else.” But I took the job because I needed the job, I needed money, and I ended up falling in love with it. I fell in love with the plant. I fell in love with learning about the plant and learning about all the different science of cannabis, behind cannabis, and I also loved connecting with consumers and really helping them reframe their relationship with cannabis as medicine, and helping them to kind of take control of their own health and wellness journey and regain some agency with this awesome medicinal plant. And so I stayed there, I stayed in Farma in total for about two years, but I budtended for about four to five months and then I was named, of course, Portland’s Best Budtender by the Willamette Week readers poll in 2016, which was awesome, and then quickly after that became Farma’s general manager.

TG Branfalt: What about Sativa Science Club? Explain to the listeners what that is.

Emma Chasen: Yeah, sure. Sativa Science Club is a really collaborative effort to support the cannabis industry at large and a lot of the way in which we believe that we can support the industry is through education. I linked up with Sativa Science Club founder, Mary J. Poppins, in June 2017 and we just found that we had a lot of similarities in terms of our goals and hopes and visions for supporting the cannabis industry. I had stepped down from my position as GM at Farma in April of 2017 to really start to cultivate and develop a comprehensive training curriculum for industry professionals, because there just was not any kind of training on cannabis science or empathetic client care, patient care as I call it. So, the ability to really take this science, this foundational information on cannabis and distill it in a way that is accessible and meaningful to consumers in a high-traffic retail environment, it takes a little bit of finesse.

I got to work as Farma’s director of education in April of 2017, after I stepped down as their GM, to really develop a training program and then linked up with Mary of Sativa Science Club in June. Found out we had a lot of similarities and we started working together to kind of workshop classes throughout the summer and then in September of 2017 I ended up officially transitioning out of Farma and working with Sativa Science Club to develop what we call now the Core Science Certification Program. So, it is a comprehensive training program that takes you through cannabis botany, cannabis compounds, the endocannabinoid receptor system, consumption methods, as well as empathetic or compassionate client care. This curriculum was reviewed by a board of scientists so that we can make sure that all the information is good and airtight.

I mean, we don’t know a lot about cannabis right now. We have a little bit of information, but even that little bit of information has been enough to create this training program and I do believe that it’s enough to elevate the industry from the conversations that are so commonly being had now.

TG Branfalt: That’s really cool stuff. At Farma, correct me if I’m wrong about this, but you guys rejected the indica/sativa binary, instead focusing on chemotypes to determine effect. Would you please explain what that means?

Emma Chasen: Absolutely. At Farma, that was really the place where I got my foundational understanding of cannabis and what Farma does, which is really pretty radical when you look at the way in which other dispensaries talk about cannabis flowers. They reject this indica/sativa binary. In cannabis, we commonly associate cannabis indica with being super sleepy and “in-da-couch” and cannabis sativa as really energizing and kind of hyperactive. However, that dichotomy is incorrect for a couple of reasons. One, cannabis indica and cannabis sativa only describe the way in which plants will grow.

So, when these species were first classified by philosophers and scientists in the 1700s, they never smoked these plants, they never consumed these plants and then wrote down in their notes like, “Oh, cannabis indica, super sedative.” All they did was outline like, “Oh, cannabis indica grows short and bushy, has dense compact flowers, whereas canvas sativa grows tall and skinny, has loose flowers.” Even at the creation of these terms there is no account that they were ever associated with effect to begin with. However, if they were at some point associated with consistent experience, it still would not matter now because everything on the current cannabis market is genetically a hybrid. Everything has been crossed and prolifically bred so many times that all current cannabis cultivars are a combination of indica and sativa genetics.

It doesn’t make sense to look up online or look up on Leafly and go, “Oh, Grape Ape. They say that that’s cannabis indica. You’ll definitely get a super sedative effect from that strain every single time.” We don’t have that consistency in the supply chain yet and also, if you think about it, it just makes more sense to look at the actual chemical compounds found inside of a plant’s matrix to determine what effect or what experience it will induce and that’s because we are actually physically consuming those compounds. We’re not consuming indica or sativa, that’s kind of like amorphous term that doesn’t really tell us much about the way in which it’s going to affect us. We’re consuming the compounds that will then alter our physiology and create a specific experience.

So, when we say we reject the indica/sativa binary and instead look at the cannabis chemotype to determine effect, the cannabis chemotype is those chemical compounds found inside the plant’s matrix that actually alter our physiology to determine or create a certain experience. At Farma we never classified our cannabis and they still don’t base on the indica/sativa binary. Instead, we looked at every single cultivars lab results, cannabinoid potency as well as terpene potency to better project an experience or effect.

TG Branfalt: In a lot of my conversations I’ve been having, especially recently and this I’ve sort of noticed in the last year with business owners and growers, is there seems to be this movement towards terpene content versus strain names when it comes to marketing, when it comes to how they discuss that with their clients. Would you like to see an industry wide shift toward marketing cannabis flowers differently?

Emma Chasen: I would. I would definitely like to see this removal of the indica/sativa binary as this thing that we hold onto so tightly to tell us an experience. I think that, especially moving forward and as the legal cannabis industry evolves, consumers are going to demand predictability and consistency in their medicine. If we continue to just look at the indica/sativa binary or strain names to help us determine effect, then we will not be delivering that consistency to our consumers. To me, that’s inexcusable because then you’re potentially losing consumers and there is still a lot of negative stigma out there about cannabis and we can’t really afford to lose consumers at this point.

We need to create a different kind of approach. I do think that strain names, they’re a great marketing tool. I think that they’re an easy way to entice consumers to try something out. However, we need to be expanding the conversation and looking at the terpene content as well as the cannabinoid content, as well as the genetics, to better determine or predict an experience for the consumers, so that they can have that greater or higher level of consistency and predictability in their medicine.

TG Branfalt: I want to dig a bit deeper into sort of this education process that you do and sort of your experience with that, but before we do that we’ve got to take a break. This is Ganjapreneur.com podcast. I’m TG Branfalt.


If you were looking for a job in the rapidly growing and highly competitive cannabis industry, Ganjapreneur.com is the place to look. Visit the Ganjapreneur job board today to browse current openings with cannabis companies throughout the United States, from entry level budtender positions to executive level career opportunities. You can also create a profile and upload your resume to be discovered by cannabis recruiters. Visit our job board at Jobs.Ganjapreneur.com to create your profile today.

If you are a business owner, you can post your job openings for as little as $25 on our job board to reach the largest and most engaged audience of cannabis professionals on the web. Companies who are listed in the Ganjapreneur business directory are eligible for free job listings. If you’re already signed up, contact us today via the website or send us an e-mail at Grow@Ganjapreneur.com to activate your unique coupon.


TG Branfalt: Hey, welcome back to the Ganjapreneur.com podcast. I’m your host TG Branfalt, here with Emma Chasen, cannabis science educator and consultant for the Sativa Science Club. In your opinion, somebody who educates people on the cannabis plant, what do you think is the biggest gap in the cannabis knowledge base of consumers?

Emma Chasen: I think that it is this indica/sativa question. A lot of novice consumers who are looking to try out cannabis or explore cannabis look to popular blogs on the internet, look to sites like Leafly to help them kind of uncover the language needed to speak about cannabis. So, they find a lot of indica and sativa, cannabis indica makes you sleepy, cannabis sativa makes you energized. So, that’s still one of the biggest gaps in education that I see and dispensaries in the legal industry proliferate this idea and that definitely doesn’t help either. There’s also, as the CBD market continues to rise a huge gap in understanding the difference between hemp derived CBD and cannabis derived CBD. I can explain a little bit about that quick rundown.

TG Branfalt: Absolutely.

Emma Chasen: Hemp derived CBD and cannabis derived CBD, they are the same molecules. If you pulled out CBD from hemp and you pulled out CBD from cannabis they would look exactly the same. They are exactly the same. However, hemp took a very different breeding pathway than the cannabis plant or the “drug cultivar cannabis”. Hemp is actually a subspecies of cannabis sativa. However, it was never bred prolifically like the drug cultivar cannabis for its secondary compounds. Secondary compounds are the compounds like cannabinoids and terpenes that actually have or hold the medicinal qualities of cannabis.

Instead, hemp was bred for its primary compounds or its fibers and proteins. It was bred to clean up soil. It was bred to eventually be made into a textile or paper, food, and these are all breeding techniques specifically for primary compounds. So, you don’t really get this high level of secondary compounds. Whereas cannabis, or the drug cultivar cannabis, was bred only for its secondary compounds and it was bred illegally for a very long time for its cannabinoid potency, for its terpene potency, and this created quite a diverse range of secondary compounds. Cannabis’ real medicinal efficacy lies in this diverse range of secondary compounds and this is a theory called the entourage effect, that all of these secondary compounds are working together to create the most medicinal experience possible.

When we talk about hemp derived CBD tinctures or products, it can still be medically efficacious, it can still work because again, that CBD molecule is the same whether it’s in hemp or this cannabis drug cultivar. However, it does not have that full range of secondary compounds behind it to support the way in which CBD interacts with our physiology. You may find that your hemp derived CBD tincture doesn’t work as well as something that’s a cannabis derived CBD tincture. Also, you need to watch out for companies who are just looking to capitalize on the CBD movement. There are a lot of the elixirs that are sold online, that are sold on Amazon that really highlight, oh, CBD tincture, but then you read the fine print and it’s just hemp seed oil.

There are a lot of companies who are, unfortunately and really awfully, trying to pull one over on the consumer market and profitize on the CBD movement. So, just be careful. If you are looking to source hemp CBD, you can find reputable companies, you can find companies who are testing for both pesticides and potency and you can find something that is really clean and effective, you just have to do your research. Don’t just click on any CBD tincture that you find. Make sure that you read the fine print. The wonderful thing about hemp CBD is that it is legal. It is federally legal. So, it is accessible in all 50 states. It is accessible nationwide. So, if you do find that maybe you could benefit from CBD medicine. If you’re looking to try it out, but you’re not currently in a legal cannabis state, then you can source hemp CBD product, just make sure you do your research.

TG Branfalt: The other question I have for you is the … you said earlier that we don’t know much about the cannabis plant, we really only had 50 years of research on this plant. I mean, this might be a loaded question here, but what do you think is the biggest gap in sort of this knowledge base? What are we missing, do you think, that would help us maybe connect some dots or paint the picture a little clearer?

Emma Chasen: Sure. We’re missing a large portion of those secondary compounds in cannabis’ plant matrix. So, in my previous answer, when I described how cannabis’ real efficacy lies in that full range of secondary compounds, we only know a very small fraction of what those compounds actually are and what they do. Right now we really only know that there are cannabinoids, terpenes and flavonoids, but we don’t even really know how the flavonoids interacts with the cannabinoids and terpenes and there have been predicted or hypothesized to be hundreds and hundreds of compounds in the cannabis matrix and we only know three classes of them, the cannabinoids, terpenes and flavonoids. Again, we only really know what two of those, the cannabinoids and terpenes, actually do and how they work, and still, with those two classes, we don’t quite fully understand how they’re interacting with our physiology. We need a lot more research to uncover the rest of the secondary compounds in the cannabis matrix so that we can better understand how cannabis can be used as medicine.

TG Branfalt: Who do you think should be leading the way in this research? Right now a lot of private entities and legal states are working to map the genome or do other research like that. There’s a higher education programs that are working primarily with hemp. There’s a good one in New York. There’s a great one in Vermont. State governments are issuing reports, but not really doing research. The federal government has no interest, but who do you think should be leading the research efforts?

Emma Chasen: I think that higher education is always a great way to conduct and fund research. However, higher education gets tricky. If it’s federally funded, then they don’t really want to touch cannabis. The state doesn’t really give much money to support research efforts on cannabis, so that leaves you with private entities, which can gain funding from a variety of different investors to do this kind of research and with that I’m slightly conflicted on whether I like the fact that private entities are leading research. I do think that there are many private entities such as Phylos Bioscience here in Portland, that is a cannabis genomics company that is trying to synthesize the entire cannabis genome, but they also have this nonprofit that’s part of their organization called the Open Cannabis Project that looks to publish this information in open source so that nobody can patent the cannabis genome.

I think that that is really important, this discussion of patents that’s coming out of private entities doing research will definitely impact the way that the industry can move forward and I am not a big fan of patents or patenting cannabis. I think that that is an awful road to go down. The federal government already has a couple of patents out on cannabis and that will just make sure that only a very few number of really rich people are allowed to grow certain cultivars or certain cannabis genetics and that is not the way that I want to see this industry move forward. I want to make sure that everybody has access and the ability to grow this plant and that not a couple of rich people own it. Private entities, I think that they’re good for now. I think that moving forward, as the legalization movement gains more traction and it spreads, I think that higher education would also be the be a great place to conduct much of the research.

TG Branfalt: I’ve got to, I really have got to agree with you that, especially … as the conversation on a federal level here, do we deschedule it, do we reschedule it and I warn people quite frequently if it’s rescheduled, it’s going to put cannabis in the hands of pharmaceutical companies and people who can get FDA approval. I just think it’s worth noting that the deschedule versus reschedule conversation and I want to talk about some more Oregon-centric issues and topics and about your work at Farma. Before we do that we got to take a break. This is Ganjapreneur.com podcast. I’m TG Branfalt.


At Ganjapreneur we have heard from dozens of cannabis business owners, who have encountered the issue of cannabias, which is when a mainstream business, whether a landlord bank or some other provider of vital business services refuses to do business with them simply because of their association with cannabis. We have even heard stories of businesses being unable to provide health and life insurance for their employees because the insurance providers were too afraid to work with them.

We believe that this fear is totally unreasonable and that cannabis business owners deserve access to the same services and resources that other businesses are afforded, that they should be able to hire consultation to help them follow the letter of the law in their business endeavors and that they should be able to provide employee benefits without needing to compromise on the quality of coverage they can offer. This is why we created the Ganjapreneur.com business service directory, a resource for cannabis professionals to find and connect with service providers, who are cannabis friendly and who are actively seeking cannabis industry clients.

If you are considering hiring a business consultant, lawyer, accountant, web designer or any other ancillary service for your business go to Ganjapreneur.com/businesses to browse hundreds of agencies firms and organizations who support cannabis legalization and who want to help you grow your business. With so many options to choose from in each service category, you will be able to browse company profiles and do research on multiple companies in advance so you can find the provider who is the best fit for your particular need. Our business service directory is intended to be a useful and well-maintained resource, which is why we individually vet each listing that is submitted. If you are a business service provider who wants to work with cannabis clients, you may be a good fit for our service directory. Go to Ganjapreneur.com/business to create your profile and start connecting with cannabis entrepreneurs today.


TG Branfalt: Hey, welcome back to Ganjaprenuer.com podcast. I’m your host TG Branfalt here with Emma Chasen, cannabis science educator and consultant for Sativa Science Club, super smart. How do you think, if at all, your approach to cannabis led to your Best Budtender win in 2016?

Emma Chasen: I think that one, having a foundational understanding of how the cannabis plant interacts with human physiology really does help budtenders and it definitely helped me make better predictions for how that cannabis cultivar will make somebody feel and that is really important. When you’re working with a customer, if you give them a prediction and that prediction turns out right, then they’re more likely to come back to you and get medicine from you. There are also, of course, are other things that I would always include in the conversation such as dosing guidelines. So, telling people how to specifically use this product, maybe start at night if you’re a novice just in case you experience some drowsy effects you could sleep it off. Start with a very, very low dose or a micro dose and then wait a few minutes, wait 10 minutes to see how that product makes you feel before consuming more so that way you can ensure that you won’t have such an uncomfortable experience if it doesn’t work for you.

I also definitely prize myself, I guess, on my ability to take really scientific jargon-heavy concepts and distill them down in a way that a lay person can understand. So, being able to explain these kinds of scientific concepts in a way that is accessible and not alienating, because I think that a lot of times when people do try to educate, it creates this like distancing or othering of the other person on the other side of the conversation because they don’t know it or they feel like you’re patronizing them or whatever it may be. So, I always tried and I always did meet people where they were at and if they weren’t looking for the education, then I wasn’t about to give it to them.

A lot of people ask me all the time like, “Well, what happens if you do get a customer who comes in and is like, ‘I want your heaviest cannabis indica.’ What do you say to that?” My response is there are ways to very slyly insert some education in that conversation and so if somebody comes in and says, “I want a heavy cannabis indica.” I’m not going to correct them, that is like customer service 101, the customer’s always right. I then follow up with what a question, “Okay, what kind of experience are you looking for? Do you want something that’s more sedative?” Usually they’ll say, “Yeah, I want something to just put me out, again, heavy indica.” And maybe then I’d pull out a cultivar for them to smell and talk about how it has a high concentration of THC and a high concentration of a terpene called myrcene and myrcene is found abundantly in hops.

So, think when you drink a few beers and you get drowsy. Well, that’s what this call cultivar is going to do to you. Never in that conversation did I say, “You’re wrong. Indica is wrong.” You can’t say that. Never did I also say, “Oh yeah, I’m going to get you a cannabis indica, a heavy indica.” I kind of did my own sly insertion of education and they took home something that hopefully will give them the experience that they want and maybe that planted a tiny seed so that the next time they come into the dispensary they’ll ask for something that’s high in myrcene instead of an indica. I think that that approach made me really successful as a budtender. It’s this combination of being able to explain cannabis science to people or introduce them to cannabis science in a way that is not othering or alienating and then also combining that with a really high level of customer service, which includes active listening, which includes eye contact, open body language, like a high degree of excitement.

A lot of people who come into a dispensary are really, really excited to be there and so the budtender has to match that excitement, otherwise it’s going to be a little bit of a disappointment for the customer. So, really all those things combined. That high level customer service casual professionalism, plus this foundational understanding of cannabis science and being able to articulate it in a way that makes sense to people.

TG Branfalt: In my sort of daily news writing and conversations with industry owners, a lot of people say that Oregon’s program is one of the more interesting in terms of the employment there, you have to get a permit as an employee, and the program was recently criticized by the US Oregon District Attorney Billy J. Williams, saying that it has a massive overproduction problem among other things. Talking a lot about diversion. As somebody who’s been in the industry, what changes, if any, would you like to see in Oregon’s adult-use regime and is William’s criticisms worthwhile?

Emma Chasen: Well, I think that Oregon, out of the legal recreational states thus far, actually does have one of the better programs. The legislature is, I think, a lot better than the approach that Colorado and Washington took in that the craft industry really thrives in Oregon, specifically Portland, and we’ve seen that with craft coffee, craft wine, craft food and so why not craft cannabis? It is true that there is a strong foothold of this craft movement here. I’m part something called the Craft Cannabis Alliance here in Oregon, that really seeks to make sure that small, home-grown Oregon owned companies really make it in this industry, because it is tough.

To comment on this massive overproduction problem that we’re seeing in Oregon, it’s true. We are seeing a massive overproduction problem. This past fall market and flooded with products, specifically cannabis flour and nobody was buying it. That drove the prices down in an insane amount. I mean, I heard of pounds being sold for $200, which is awful. I mean, you cannot make money off of that. However, this is not a problem specific to Oregon. We’ve seen this problem happen in Colorado. We’ve seen it happen in Washington. I’m sure it will happen in California, where the state does not put a moratorium or a cap on licenses. It’s free market. It’s capitalism. Anybody can go out for a license. However, at this point there are only about 14% of the population in Oregon that consume cannabis and that number is not growing.

You bring on more licenses, you bring on more businesses that have more product and yet your consumer base isn’t growing. So, it’s inevitable that some of those companies are going to drop out or turn to black market, which a lot of them are. There are two solutions, a few solutions I see to this problem. One, the state could put a cap on licenses and say, “You know what? There are only allowed this many licenses in the state.” However, a lot of people do not jive with that idea because capitalism, free market, we want to let everybody have a chance, which I totally get. The next thing would be, okay, as the East Coast starts to legalize, as Vermont, as New Jersey, as Maine, Massachusetts legalize, you can’t really grow great cannabis naturally out there. You have to grow it in a warehouse, which, of course, is not very sustainable and costs a lot more money and is not good for the environment.

Then the solution becomes, “Well, if we have all this product out in Oregon, that is arguably the best cannabis product that you are going to get. This is the place that has been growing cannabis forever. It’s the place that has been supplying the East Coast black market forever, so why not regulate that? Why not allow Oregon companies to ship product out to East Coast legal States and have that flower be sold in their dispensary instead of popping up all these warehouses that are just generating “botox weed”, as I call it. So, that would be a larger solution. However, of course, then you need to get the feds involved because you’re crossing state lines. It’s not something that’s going to happen right away, but it’s something that long term could potentially really help the Oregon market, but I think that for right now it’s really making sure that these craft companies do survive because they are the heart of the Oregon market and that in this shakeout not having just like a few highly capitalized companies kind of win out.

TG Branfalt: Are you, with the recent changes in federal policy, the revocation of the Cole Memo, are there any fears of crackdown among operators in Oregon?

Emma Chasen: I think it was a big scare when Sessions rescinded the Cole Memo. People definitely freaked out a little bit. However, as long as the state’s attorney general is cool with it, as long as they are not going to come after the program, then it’s going to be okay, and they’re not going to come after the program unless people are not remaining in compliance. So, unless people are selling to black market prolifically and the whole kind of market and industry just bottoms out, which again, it is definitely a risk right now with this kind of market shakeout that’s happening. However, I don’t think that the state’s attorney generals are going to go after companies and just shut the industry down.

I mean, it’s making a ton of money for the state, millions of dollars in tax revenue are coming in. There are now a ton of jobs that are being created due to this industry. There are people who are not dying of opioid overdoses. I mean, we’ve seen in every single sector how this industry can benefit the states and so, unless we have an industry wide problem of everybody turning to black market activity, then I don’t think that there is really going to be a major shutdown.

TG Branfalt: Usually I end these interviews by asking what advice would you have for entrepreneurs, but really, I think what I want to know from you is, what advice do you have for people interested in working on the retail side, working in the customer service aspect of the cannabis space?

Emma Chasen: I’d say, “Do your research. Learn.” You can now take our program at SativaScienceClub.com. You could take the core science certification program from anywhere in the world because we do have it set up for online students as well. So, make sure that you learn about cannabis, make sure that you learn how to talk about it and then do your research and really target the dispensaries that you align with, and then take whatever position you can get there. This is the main thing I say to everybody looking to get into the cannabis industry, just get your foot in the door.

I mean, when I got to Portland I didn’t want to be a budtender working for $12 an hour. That was not something that I wanted to do, but I did it and then I worked my ass off to find my niche and made connections and networked until I eventually got where I wanted to be. So, do your research, learn as much as you can about cannabis and about how to talk to people about it and then go out and just take a position that you can, meet people, connect and continue climbing your way.

TG Branfalt: I really want to thank you for being on the show. This has been really, really cool. You have a fountain of knowledge. You know a lot more than I do, that is for sure. Where can people find out more about you more and more about the Sativa Science Club, other projects that you might have going on.

Emma Chasen: Sure. You can find Sativa Science Club at SativaScienceClub.com and you can find out all about the training and workshops that you can take through there. You can also find me and the work that I do at EmmaChasen.com. You can also find me on Instagram and Facebook. So, my socials. On Instagram I’m echasen. Facebook, Emma Chasen. Same with Sativa Science Club. You can find them all over social media, Instagram, Facebook and the like.

TG Branfalt: Again, thank you so much for taking the time to come on the show. It’s really been delightful and I definitely look forward to talking to you again for sure.

Emma Chasen: Yes, thank you so much for having me on. It’s been my pleasure. So fun.

TG Branfalt: You can find more episodes of the Ganjapreneur.com podcast in the podcast section of Ganjapreneur.com and in the Apple iTunes store. On the Ganjapreneur.com website you’ll find the latest cannabis news and cannabis jobs updated daily, along with transcripts of this podcast. You can also download the Ganjaprenuer.com App in iTunes and Google Play. This episode was engineered by Trip Media House. I’ve been your host, TG Branfalt.

End


An orange pill bottle is knocked over on a white surface, spilling anonymous pharmaceuticals out in front of it.

Death Toll Rising: U.S. Opioid Overdose Rates Jump 30 Percent in One Year

a word from our sponsors:

advertisement

advertise here

At Ganjapreneur, we’ve written time and again about the opioid epidemic ravaging the United States. This is not a new issue — but it is getting worse. 

The Center for Disease Control (CDC) recently released the results of a year-long study which tracked overdose-related hospital visits throughout the U.S. between June 2016 and September 17. During the course of that year, opioid overdose rates rose on average by 30 percent throughout the country.

The Midwest saw the most alarming changes, with overdose rates surging up 70% — Wisconsin experienced the worst rise, a 109% increase — but every major region of the country has seen overdose rates go up. Overdoses in large cities increased on average by 56% and, according to the report, individuals who have had at least one overdose already are more likely to suffer another.

Opioids do not discriminate based on age, sex, race, or economic status: every community is affected and everyone — whether directly as an addict or indirectly as a family member, friend, or bystander — is a potential victim. Opioid users frequently become hooked on doctor-prescribed pharmaceutical painkillers and, when their prescription runs out, turn to black market sources for said pharmaceuticals (or for heroin).

In its report, the CDC makes several recommendations to help federal agencies, state governments, and individuals better prepare themselves for the fight against deadly narcotics. Some of these tips include streamlining communications between state health departments and their local communities, increasing the distribution of overdose-reversing drugs such as naloxone, and the use of prescription drug monitoring programs. Notably, the CDC fails to mention the rising popularity of an effective pain treatment that is both non-toxic and non-addictive: medical cannabis.

Multiple studies have shown that opioid overdose rates have gone down in states with an established medical marijuana program, especially if said program allows access to the plant as a treatment for chronic pain. In fact, patients consistently indicate that they were able to decrease or entirely halt their opioid intake by switching to cannabis and, even with the number of cannabis users steadily increasing, there remain zero recorded deaths attributed to a cannabis overdose.

Dissenters and an alarming number of lawmakers, however, continue to tout disproved, Drug War-era theories about the gateway effect or some other half-cocked excuse like, “We haven’t done enough research yet,” or my personal favorite, “We shouldn’t increase access to an illegal drug during times of crisis” — as if a thing could be good or bad for you based on something as arbitrary as its legality.

This CDC report might have just been released, but nothing in this article is new except the rising number of victims. Lawmakers, companies, and individuals who refuse to take action on this issue or who are purposefully blocking medical cannabis reforms should be seen as complicit in the opioid epidemic’s daily death toll, which last year surpassed 170 Americans per day.

End


Oklahoma House Unanimously Approves Bi-Partisan Industrial Hemp Bill; Moves to Senate

a word from our sponsors:

advertisement

advertise here

Oklahoma’s House has unanimously approved an industrial hemp pilot program bill which would allow the state’s farmers to obtain a license to grow the crop, KOKH reports. The measure is sponsored by Democratic Rep. Mickey Collens and Majority Floor Leader Jon Echols, a Republican.

“The potential provided in this bill is limitless. In the long term, industrial hemp could become a source of steady, recurring revenue for Oklahoma. Once we analyze results from this pilot program, our state can be on track to commercialize the product and strengthen our economic portfolio.” Dollens to KOKH

The program would be overseen by the state Department of Agriculture, Food and Forestry, allowing farmers and institutes of higher education to partner with one another to cultivate certified hemp seed – for plants containing 0.3 percent THC – for research and development purposes. The measure includes creating a fund using fees paid by program participants for that agency to register growers, test products, and inspect cultivation sites; however, the legislation does not outline what those fees are.

The bill has been sent to the Oklahoma Senate. If approved by the legislature, the measure would take effect immediately after being signed by the governor.

End